Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jesper Säfholm (Stockholm, Sweden), Jesper Säfholm, Martijn Manson, Johan Bood, Ingrid Delin, Ann-Charlotta Orre, Per Bergman, Mamdoh Al-Ameri, Sven-Erik Dahlén, Mikael Adner. Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways. Eur Respir J 2015; 46: Suppl. 59, 4465

Member's Comments

No comment yet.

Related content which might interest you: Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 HMGB1 is upregulated in ASM in asthma and induces ASM contraction via TLR4 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration Source: International Congress 2014 – Cell biology 2014 Year: 2014 Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 MNK-1 inhibition reduces proliferation and CXCL10 in airway smooth muscle cells Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Eosinophil-induced airway smooth muscle cells remodeling is attenuated by blocking of RGD-binding integrins in asthma Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 DP2/CRTh2 is expressed by ASM cells in asthma and its inhibition suppresses ASM migration Source: International Congress 2016 – Mechanisms of disease Year: 2016 Effect of resolvin D1 on leukotriene D4-induced constriction of rat and human bronchioles Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 The effect of JQ1/SGCBD01 upon c-Myc in human airway smooth muscle in asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Involvement of purine metabolites in dsRNA-induced IL-33 expression in human bronchial smooth muscle cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014